Sep 10, 2024, 17:17
Bruna Pellini: Why should we study circulating tumor DNA
Bruna Pellini shared a post on LinkedIn:
“Why should we study circulating tumor DNA (ctDNA)?
Discover how my research on ctDNA aims to uncover cancer drivers, enable earlier diagnosis, and pave the way for new treatments Moffitt Cancer Center, Moffitt Oncology Network.”
Proceed to the video attached to the post.
Source: Bruna Pellini/LinkedIn
More posts by Bruna Pellini on oncodaily.com
Bruna Pellini is an Assistant Professor at the University of South Florida and an Assistant Member in the Department of Thoracic Oncology at Moffitt Cancer Center. Her research centers on the use of liquid biopsies to monitor treatment response, detect minimal residual disease (MRD), and integrate these techniques into clinical trials.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 20, 2024, 20:38
Nov 20, 2024, 20:27
Nov 20, 2024, 19:12
Nov 20, 2024, 19:12
Nov 20, 2024, 19:12
Nov 20, 2024, 19:12